Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] - 03/08/24

Montserrat Torres ^a, Guiomar Casado ^a, Lorena Vigón ^a, Sara Rodríguez-Mora ^{a, b}, Elena Mateos ^{a, b}, Fernando Ramos-Martín ^a, Daniel López-Wolf ^c, José Sanz-Moreno ^d, Pablo Ryan-Murua ^e, María Luisa Taboada-Martínez ^f, María Rosa López-Huertas ^{a, b}, Miguel Cervero ^g, Mayte Coiras ^{a, b, ⁎}

on behalf of Multidisciplinary Group of Study of COVID19 (MGS-COVID)1, Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order)

^a Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain 

^b Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Spain 

^c Internal Medicine Service, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain 

^d Internal Medicine Service, Hospital Universitario Príncipe de Asturias, Alcalá Henares, Spain 

^e Internal Medicine Service, Hospital Universitario Infanta Leonor, Madrid, Spain 

^f Internal Medicine Service, Hospital Universitario de Cabueñes, Gijón, Spain 

^g Internal Medicine Service, Hospital Universitario Severo Ochoa, Leganés, Spain 

^⁎Correspondence to: Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Ctra. Majadahonda-Pozuelo km2, Madrid 28220, Spain.Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos IIICtra. Majadahonda-Pozuelo km2Madrid28220Spain

Le texte complet de cet article est disponible en PDF.